LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
185,500
-10,600 (-5.41%)
At close: Dec 5, 2025
74.18%
Market Cap 6.75T
Revenue (ttm) 159.27B
Net Income (ttm) -25.13B
Shares Out 36.41M
EPS (ttm) -691.70
PE Ratio n/a
Forward PE 129.84
Dividend n/a
Ex-Dividend Date n/a
Volume 707,234
Average Volume 659,369
Open 195,000
Previous Close 196,100
Day's Range 180,200 - 198,400
52-Week Range 89,500 - 203,500
Beta 0.74
RSI 58.29
Earnings Date Nov 14, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.